Literature DB >> 6252918

A more general role for WR-2721 in cancer therapy.

J M Yuhas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252918      PMCID： PMC2010320          DOI： 10.1038/bjc.1980.150

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  Differential chemoprotection of normal and malignant tissues.

Authors:  J M Yuhas; J B Storer
Journal:  J Natl Cancer Inst       Date:  1969-02       Impact factor: 13.506

2.  Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine.

Authors:  J M Yuhas
Journal:  Cancer Treat Rep       Date:  1979-06

3.  Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.

Authors:  L C Washburn; J E Carlton; R L Hayes
Journal:  Radiat Res       Date:  1974-08       Impact factor: 2.841

4.  Misonidazole enhancement of acute and late radiation injury to the rat spinal cord.

Authors:  J M Yuhas
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640
  4 in total
  2 in total

1.  The effect of 2-[(aminopropyl)amino] ethanethiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells.

Authors:  C P Sigdestad; S H Treacy; L A Knapp; D J Grdina
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

2.  Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

Authors:  J M Yuhas; J M Spellman; S W Jordan; M C Pardini; S M Afzal; F Culo
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.